# Budesonide Treatment for Lymphocytic Colitis

> **NCT00180050** · PHASE3 · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 40 (estimated)

## Conditions studied

- Microscopic Colitis

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT00180050
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2006-08
- **Final completion:** 2007-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180050, "Budesonide Treatment for Lymphocytic Colitis". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00180050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*